|Day Low/High||90.25 / 91.70|
|52 Wk Low/High||62.55 / 97.86|
I have always liked the aggressive management.
A lifting on the moratorium on elective procedures could be a big win for ABBV.
What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.
The market sold off on Thursday after close as big hitters, including Amazon, reported earnings.
When it's beaten you will wish you own stocks, especially the stocks that are right now lethal to your portfolio.
After a company reports we all know what's wrong, it's immunized. And that's when you can buy.
JNJ should survive a recession and prove in demand in a health crisis.
Here again is my approach and my three stock groups: 'rebound', 'revenue' and 'virus'.
Here are six companies that should come through in the tough times ahead.
You can use these wild market swings to your advantage by identifying 'safe' companies you want to own and then buying their stocks in stages.
But don't throw up your arms yet -- here are names that could be golden opportunities.
This is the time to high grade your portfolio, take some losses and move to better stocks.
Let's review the charts and indicators.
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.
This rally has been industry, not sector led, and it is all based on technology, whether or not market leaders reside within the Tech sector or not.
Merger activity is the number 1 driver I am watching for biotech growth.
I'm watching the shares of Estee Lauder, Disney and Amazon.
AbbVie's weekly chart indicates its stock has room to run long term, but its daily chart suggests a rally in its shares is not imminent.
I think, ultimately, the big issue for many will be what happens in the United States if we hear about people who didn't go to China who have come down with the disease.
Nobody in AbbVie right now is in it for the past performance.
ABBV could bounce today but there remains the risk of a deeper correction.
Chinese President Xi Jinping, not a man given to exaggerate, has referred to the spread of this coronavirus in China as 'a grave situation.'
These companies all could be strong -- even if the 2019 nCoV fear spreads.
The Medical Technology Stock Letter's top pick rose 357% in 2019.
How to prepare your portfolio and be opportunistic in the face of this geopolitical instability.
As it smooths out the wrinkles from 2019, this pharmaceutical manufacturer should have a healthy year.
This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.